Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Apr 14, 2010


OncoMethylome Sciences' board of directors has named Jan Groen to serve as the company's chief executive officer.

With more than 25 years of experience in the clinical diagnostics industry, Groen was previously the president and chief operating officer of Agendia, responsible for the firm's US and European operations. He was also VP of research and development of Quest subsidiary Focus Diagnostics, and has held numerous management and scientific positions at ViroClinics, the Erasmus Medical Center, and Akzo-Nobel.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.